Skip to main content
OpenTrials

Clinical trial condition

Endometrial Carcinoma

Explore clinical trials studying Endometrial Carcinoma. Study availability and eligibility vary by location and protocol.

79 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Carcinoma trial results

Completed

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

NCT04080284

Conditions
Cancer of the Endometrium, Endometrial Cancer, Endometrial Carcinoma, +14 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Rutgers NJ School of Medicine Newark, New Jersey, United States
  • Imbert Cancer Center Northwell Health Bay Shore, New York, United States
  • Greenlawn Cancer Institute, Northwell Health Greenlawn, New York, United States
View Trial Details
Completed

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

NCT02611024

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Tumors, +53 more
Locations
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Massachusetts General Hospital - Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 23 locations
View Trial Details
Completed

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

NCT06789224

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +74 more
Locations
  • Kliniken der Stadt Köln gGmbH Cologne, North Rhine-Westphalia, Germany
  • Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik für Anästhesiologie Mainz, Germany
  • Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie Mannheim, Germany
View Trial Details
Completed

A Study of Nivolumab in Selected Uterine Cancer Patients

NCT03241745

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +25 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

UTOLA: UTerin OLAparib

NCT03745950

Conditions
Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • ICO Paul Papin Angers, France
  • Institut du cancer Avignon-Provence Avignon, France
  • CHRU Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
View all 36 locations
View Trial Details
Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Completed

A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

NCT03015129

Conditions
Disease Attributes, Endometrial Cancer, Endometrial Cancer Recurrent, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details

Related conditions